Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review

Treatment with pharmacological drugs for colorectal cancer (CRC) remains unsatisfactory. A major cause of failure in pharmacotherapy is the resistance of colon cancer cells to the drugs, creating an urgent issue. In this review, we summarize previous studies on the resistance of CRC cells to irinote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozawa, Shogo, Miura, Toshitaka, Terashima, Jun, Habano, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992440/
https://www.ncbi.nlm.nih.gov/pubmed/35582377
http://dx.doi.org/10.20517/cdr.2021.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992440/
https://www.ncbi.nlm.nih.gov/pubmed/35582377
http://dx.doi.org/10.20517/cdr.2021.82

Ejemplares similares